During the past decade, UH Seidman Cancer Center at Saint John Medical Center conducted 72 clinical trials. In the 10-year time frame, 72 clinical trials started and 25 clinical trials were completed, i.e. on average, 34.7% percent of trials that started reached the finish line to date. In the past 5 years, 29 clinical trials started and 23 clinical trials were completed. i.e. 79.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UH Seidman Cancer Center at Saint John Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 39 trials, followed by "SWOG Cancer Research Network" with 23 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 9 trials sponsored, "Alliance for Clinical Trials in Oncology" with 7 trials sponsored and "NRG Oncology" with 7 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UH Seidman Cancer Center at Saint John Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 45 trials as a collaborator, "NRG Oncology" with 13 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Alliance for Clinical Trials in Oncology" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "UH Seidman Cancer Center at Saint John Medical Center" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Stage IV Lung Cancer AJCC v8" (6 trials), "Invasive Breast Carcinoma" (5 trials) and "Stage IIIA Breast Cancer" (5 trials). Many other conditions were trialed in "UH Seidman Cancer Center at Saint John Medical Center" in a lesser frequency.

Most popular intervention types in "UH Seidman Cancer Center at Saint John Medical Center" are "Drug" (73 trials), "Other" (52 trials), "Biological" (41 trials), "Procedure" (26 trials) and "Radiation" (17 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (25 trials), "Quality-of-Life Assessment" (22 trials), "Computed Tomography" (17 trials), "Nivolumab" (14 trials) and "Questionnaire Administration" (14 trials). Other intervention names were less common.

The vast majority of trials in "UH Seidman Cancer Center at Saint John Medical Center" are 72 trials for "All" genders, 14 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "UH Seidman Cancer Center at Saint John Medical Center". undefined are not yet recruiting, 28 are recruiting, 39 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in UH Seidman Cancer Center at Saint John Medical Center, 4 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in UH Seidman Cancer Center at Saint John Medical Center, 1 "Phase 1" clinical trials were conducted, 43 "Phase 2" clinical trials and 53 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".